Immunoliposomes for the targeted delivery of antitumor drugs

被引：133
|
作者：
Mastrobattista, E
Koning, GA
Storm, G
机构：
[1] Univ Utrecht, Fac Pharm, UIPS, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
[2] Univ Groningen, Fac Med Sci, Inst Drug Explorat, Dept Physiol Chem, NL-9713 AV Groningen, Netherlands
来源：
ADVANCED DRUG DELIVERY REVIEWS | 1999年 / 40卷 / 1-2期
关键词：
anticancer agents; immunoliposomes;
D O I：
10.1016/S0169-409X(99)00043-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This review presents an overview of the field of immunoliposome-mediated targeting of anticancer agents. First, problems that are encountered when immunoliposomes are used for systemic anticancer drug delivery and potential solutions are discussed. Second, an update is given of the in vivo results obtained with immunoliposomes in tumor models. Finally, new developments on the utilization of immunoliposomes for the treatment of cancer are highlighted. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码：103 / 127
页数：25
相关论文
共 50 条
  • [21] Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes
    Gagné, JF
    Désormeaux, A
    Perron, S
    Tremblay, MJ
    Bergeron, MG
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1558 (02): : 198 - 210
  • [22] GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs
    Ji, Qingzhi
    Zhu, Huimin
    Qin, Yuting
    Zhang, Ruiya
    Wang, Lei
    Zhang, Erhao
    Zhou, Xiaorong
    Meng, Run
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery
    Park, JW
    Hong, KL
    Kirpotin, DB
    Colbern, G
    Shalaby, R
    Baselga, J
    Shao, Y
    Nielsen, UB
    Marks, JD
    Moore, D
    Papahadjopoulos, D
    Benz, CC
    CLINICAL CANCER RESEARCH, 2002, 8 (04) : 1172 - 1181
  • [24] E-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cells
    Gholizadeh, Shima
    Visweswaran, Ganesh Ram R.
    Storm, Gert
    Hennink, Wim E.
    Kamps, Jan A. A. M.
    Kok, Robbert J.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 548 (02) : 759 - 770
  • [25] Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor
    Paul, Jonathan W.
    Hua, Susan
    Ilicic, Marina
    Tolosa, Jorge M.
    Butler, Trent
    Robertson, Sarah
    Smith, Roger
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (03)
  • [26] PH-SENSITIVE IMMUNOLIPOSOMES AS AN EFFICIENT AND TARGET-SPECIFIC CARRIER FOR ANTITUMOR DRUGS
    CONNOR, J
    HUANG, L
    CANCER RESEARCH, 1986, 46 (07) : 3431 - 3435
  • [27] Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD2-targeted immunoliposomes:: Antitumor effects
    Pagnan, G
    Stuart, DD
    Pastorino, F
    Raffaghello, L
    Montaldo, PG
    Allen, TM
    Calabretta, B
    Ponzoni, M
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (03) : 253 - 261
  • [28] LIPOSOMES AND IMMUNOLIPOSOMES FOR CONTROLLED RELEASE OR SITE SPECIFIC DELIVERY OF ANTIPARASITIC DRUGS AND CYTOSTATICS
    CROMMELIN, DJA
    ELING, WMC
    STEERENBERG, PA
    NASSANDER, UK
    STORM, G
    DEJONG, WH
    VANHOESEL, QGCM
    ZUIDEMA, J
    JOURNAL OF CONTROLLED RELEASE, 1991, 16 (1-2) : 147 - 154
  • [29] Targeted delivery of antitumor peptide lactaptin to tumors
    Kuligina, E.
    Vaskova, A.
    Kaledin, V.
    Ilyichev, A.
    Borgoyakova, M.
    Koval, O.
    Richter, V.
    FEBS JOURNAL, 2013, 280 : 316 - 316
  • [30] Immunoliposomes for Targeted Radionuclide Therapy
    Sgouros, G.
    MEDICAL PHYSICS, 2009, 36 (06)
12345